Magic mushroom therapy shows promise for depression in small trial

This early-phase study tested whether combining psilocybin (the active ingredient in magic mushrooms) with cognitive behavioral therapy is a feasible and acceptable treatment for major depression. Sixteen adults with moderate to severe depression received two doses of psilocybin plus 12 therapy sessions. The goal was to see if people would stick with the treatment and find it helpful, not to prove it works yet.